Table 1

Demographic data and incidence of type 2 DM among adolescents and young adults with ASD and the control group

Adolescents and young adults with ASD (n = 6,122)Control group (n = 24,488)P value
Age at enrollment, years (SD)15.25 (4.60)15.25 (4.60)
 <18 years, n (%)4,844 (79.1)19,376 (79.1)
 18–29 years, n (%)1,278 (20.9)5,112 (20.9)
Male sex, n (%)4,896 (80.0)19,584 (80.0)
Type 2 DM, n (1,000 person-years)95 (2.63)92 (0.63)<0.001
Age at diagnosis, years (SD)22.22 (5.89)23.06 (6.49)0.359
Duration between enrollment and type 2 DM diagnosis, years (SD)3.42 (2.11)5.35 (2.31)<0.001
Comorbidities, n (%)
 Hypertension61 (1.0)241 (1.0)0.948
 Dyslipidemia122 (2.0)380 (1.6)0.017
 Obesity166 (2.7)273 (1.1)<0.001
Use of atypical antipsychotics, n (%)<0.001
 Nonuser4,153 (67.8)24,371 (99.5)
 Short-term user990 (16.2)82 (0.3)
 Long-term user919 (16.0)35 (0.1)
Level of urbanization, n (%)<0.001
 1 (most urbanized)1,053 (17.2)7,315 (29.9)
 21,884 (30.8)7,499 (30.6)
 3549 (9.0)4,429 (18.1)
 4495 (8.1)3,365 (13.7)
 5 (most rural)2,141 (35.0)1,880 (7.7)
Income-related insured amount, n (%)<0.001
 ≤15,840 NTD/month5,548 (90.6)17,849 (72.9)
 15,841–25,000 NTD/month534 (8.7)4,556 (18.6)
 ≥25,001 NTD/month40 (0.7)2,083 (8.8)
  • NTD, New Taiwan dollar.